Literature DB >> 8250031

Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat.

C Baylis1.   

Abstract

Studies of conscious, chronically catheterized, young (3 to 5 months of age) and old (19 to 22 months of age) male Sprague Dawley rats in the baseline state showed that glomerular filtration rate (factored for body weight) was lower and urine flow higher in old compared with young rats. Acute blockade of endogenous angiotensin II (AII) with either converting enzyme inhibitor (CEI) or Losartan (Dupont Merck, Wilmington, DE) caused small variable decreases in blood pressure in both age groups and produced a significant renal vasodilation with increases in renal plasma flow in the older rats. In separate studies using low-dose AII infusion (5 ng/kg body weight/min), an increase in filtration fraction was the only effect seen in both young and old rats with an intact renin/AII system; no effect was seen with CEI. During high-dose AII (20 ng/kg body weight/min), significant and similar increases were seen in blood pressure and renal vascular resistance in old and young rats, and the patterns of blood pressure and renal hemodynamic responses were similar with and without acute CEI. A natriuretic and diuretic response to high-dose AII was seen in young rats with intact endogenous renin/AII, whereas old rats were completely refractory to this action of AII. Against a background of acute CEI, no natriuretic/diuretic response to high-dose AII was seen in either age group. Thus, in the baseline state, renal hemodynamics in the old kidney are controlled by endogenous AII since CEI and Losartan produce renal vasodilation in old but not young rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250031     DOI: 10.1016/s0272-6386(12)70344-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  Basal and stimulated nitric oxide in control of kidney function in the aging rat.

Authors:  C Hill; A M Lateef; K Engels; L Samsell; C Baylis
Journal:  Am J Physiol       Date:  1997-06

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Effects of aging and alterations in dietary sodium intake on total nitric oxide production.

Authors:  R J Schmidt; W H Beierwaltes; C Baylis
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

4.  The frail renin-angiotensin system.

Authors:  Peter M Abadir
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 5.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

Review 6.  Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.

Authors:  Debra I Diz
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

7.  Age-related declines in thirst and salt appetite responses in male Fischer 344×Brown Norway rats.

Authors:  Robert L Thunhorst; Terry Beltz; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2014-06-19

Review 8.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 9.  The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system.

Authors:  Crystal A West; Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-05

Review 10.  Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.

Authors:  Chris Baylis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-07       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.